{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T17:00:32Z","timestamp":1754154032706,"version":"3.41.2"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,23]]},"DOI":"10.7759\/cureus.88611","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T19:25:47Z","timestamp":1753298747000},"source":"Crossref","is-referenced-by-count":0,"title":["Acute Pleuropericardial Syndrome Following Messenger Ribonucleic Acid (mRNA) COVID-19 Vaccination: A Case Report"],"prefix":"10.7759","author":[{"given":"Odunayo","family":"Yusuf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajibola","family":"Omotosho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109730","article-title":"Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel","volume":"385","author":"Mevorach D","year":"2021","unstructured":"Mevorach D, Anis E, Cedar N, et al.. Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. N Engl J Med. 2021, 385:2140-9. 10.1056\/NEJMoa2109730","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021","volume":"327","author":"Oster ME","year":"2022","unstructured":"Oster ME, Shay DK, Su JR, et al.. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA. 2022, 327:331-40. 10.1001\/jama.2021.24110","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7027e2","article-title":"Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices - United States, June 2021","volume":"70","author":"Gargano JW","year":"2021","unstructured":"Gargano JW, Wallace M, Hadler SC, et al.. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the Advisory Committee on Immunization Practices - United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021, 70:977-82. 10.15585\/mmwr.mm7027e2","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7107e1","article-title":"Safety monitoring of COVID-19 vaccine booster doses among adults - United States, September 22, 2021-February 6, 2022","volume":"71","author":"Hause AM","year":"2022","unstructured":"Hause AM, Baggs J, Marquez P, et al.. Safety monitoring of COVID-19 vaccine booster doses among adults - United States, September 22, 2021-February 6, 2022. MMWR Morb Mortal Wkly Rep. 2022, 71:249-54. 10.15585\/mmwr.mm7107e1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp010731","article-title":"Pleural effusion","volume":"346","author":"Light RW","year":"2002","unstructured":"Light RW. Pleural effusion. N Engl J Med. 2002, 346:1971-7. 10.1056\/NEJMcp010731","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2010.01794.x","article-title":"Pearls and myths in pleural fluid analysis","volume":"16","author":"Porcel JM","year":"2011","unstructured":"Porcel JM. Pearls and myths in pleural fluid analysis. Respirology. 2011, 16:44-52. 10.1111\/j.1440-1843.2010.01794.x","journal-title":"Respirology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2020.05.001","article-title":"Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management","volume":"17","author":"Siripanthong B","year":"2020","unstructured":"Siripanthong B, Nazarian S, Muser D, et al.. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020, 17:1463-71. 10.1016\/j.hrthm.2020.05.001","journal-title":"Heart Rhythm"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen S","year":"2021","unstructured":"Ndeupen S, Qin Z, Jacobsen S, Bouteau A, Estanbouli H, Igy\u00e1rt\u00f3 BZ. The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. iScience. 2021, 24:103479. 10.1016\/j.isci.2021.103479","journal-title":"iScience"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.061025","article-title":"Circulating spike protein detected in post-COVID-19 mRNA vaccine myocarditis","volume":"147","author":"Yonker LM","year":"2023","unstructured":"Yonker LM, Swank Z, Bartsch YC, et al.. Circulating spike protein detected in post-COVID-19 mRNA vaccine myocarditis. Circulation. 2023, 147:867-76. 10.1161\/CIRCULATIONAHA.122.061025","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani A","year":"2020","unstructured":"Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020, 217:108480. 10.1016\/j.clim.2020.108480","journal-title":"Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39133","article-title":"A possible association between COVID-19 vaccine and complicated pleural effusion: a case report","volume":"15","author":"Oudah B","year":"2023","unstructured":"Oudah B, Abu-Abaa M, Al-Ameri N, Ghazaleh J, Vanam V. A possible association between COVID-19 vaccine and complicated pleural effusion: a case report. Cureus. 2023, 15:e39133. 10.7759\/cureus.39133","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jccase.2022.04.020","article-title":"A case of an elderly female who developed subacute pleuropericarditis following BNT162b2 mRNA COVID-19 vaccination","volume":"26","author":"Mizoguchi T","year":"2022","unstructured":"Mizoguchi T, Yokoi M, Shintani Y, et al.. A case of an elderly female who developed subacute pleuropericarditis following BNT162b2 mRNA COVID-19 vaccination. J Cardiol Cases. 2022, 26:225-8. 10.1016\/j.jccase.2022.04.020","journal-title":"J Cardiol Cases"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.46.1.77","article-title":"Refractory massive pleural effusion in systemic lupus erythematosus treated by pleurectomy","volume":"46","author":"Elborn JS","year":"1987","unstructured":"Elborn JS, Conn P, Roberts SD. Refractory massive pleural effusion in systemic lupus erythematosus treated by pleurectomy. Ann Rheum Dis. 1987, 46:77-80. 10.1136\/ard.46.1.77","journal-title":"Ann Rheum Dis"},{"key":"ref14","unstructured":"Centers for Disease Control and Prevention (CDC). myocarditis and pericarditis after mRNA COVID-19 vaccination. (2023). Accessed: May 2, 2025: https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/myocarditis.html."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/375160-acute-pleuropericardial-syndrome-following-messenger-ribonucleic-acid-mrna-covid-19-vaccination-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T19:25:48Z","timestamp":1753298748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/375160-acute-pleuropericardial-syndrome-following-messenger-ribonucleic-acid-mrna-covid-19-vaccination-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.88611","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,23]]}}}